Chester County News and Community Website
WILMINGTON, DE — Incyte (Nasdaq: INCY) is scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, providing investors with an opportunity to hear updates …
Incyte to Present Strategy Update at Goldman Sachs Healthcare Conference Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) is expanding its partnership with biotechnology software firm Genesis Molecular AI in a deal worth $120 million upfront, giving the company broader access to …
Incyte Deepens AI Drug Discovery Bet in $120 Million Deal Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) has entered a strategic collaboration with Edison Scientific to integrate an artificial intelligence platform across portions of its drug discovery and development operations, reflecting …
Incyte Expands AI Role in Drug Discovery Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) will present new clinical and preclinical data across its hematology and oncology pipeline at the 2026 European Hematology Association Congress, as the drugmaker seeks …
Incyte Advances Lymphoma, MPN Programs Ahead of EHA Data Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) recently reported 24-week Phase 3 trial results showing sustained disease control for adults with moderate atopic dermatitis treated with Opzelura cream, as the company …
Incyte Reports Extended Opzelura Eczema Trial Results Read More WILMINGTON, DE — Incyte Corporation (Nasdaq: INCY) granted equity inducement awards to newly appointed Executive Vice President and Chief Financial Officer Suketu Upadhyay as part of his employment agreement with …
Incyte Grants Equity Awards to New CFO Suketu Upadhyay Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) recently received U.S. Food and Drug Administration approval for Jakafi XR, a once-daily extended-release version of ruxolitinib, giving patients with several chronic blood disorders …
FDA Approves Once-Daily Jakafi XR for Blood Disorders Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) will present at two healthcare investor conferences in May as biotechnology companies continue using industry events to update investors on pipeline development, commercialization efforts, …
Incyte to Present Pipeline Strategy at May Investor Conferences Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) appointed Suketu Upadhyay as executive vice president and chief financial officer effective May 4, 2026, the company announced.
Incyte Appoints Suketu Upadhyay as Chief Financial Officer Read More WILMINGTON, DE — Incyte (Nasdaq: INCY) reported first-quarter 2026 revenue of $1.27 billion and total net sales of $1.10 billion, increases of 21% and 20%, respectively, from the same period …
Incyte Reports Q1 Revenue Growth as Pipeline Advances Read More